Enfusion Inc
NYSE:ENFN
Enfusion Inc
NYSE:ENFN
Price:
9.42 USD
Market Closed
Updated:
Apr 27, 2024
Balance Sheet
Balance Sheet Decomposition
Enfusion Inc
Enfusion Inc
| Current Assets | 69.9m |
| Cash & Short-Term Investments | 35.6m |
| Receivables | 28.1m |
| Other Current Assets | 6.2m |
| Non-Current Assets | 39.1m |
| PP&E | 32.6m |
| Other Non-Current Assets | 6.5m |
| Current Liabilities | 20.3m |
| Accounts Payable | 2.2m |
| Accrued Liabilities | 18.1m |
| Non-Current Liabilities | 35m |
| Other Non-Current Liabilities | 35m |
Balance Sheet
Enfusion Inc
Enfusion Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
6
|
14
|
64
|
63
|
36
|
|
| Cash |
6
|
14
|
64
|
63
|
36
|
|
| Total Receivables |
9
|
12
|
18
|
26
|
28
|
|
| Accounts Receivables |
9
|
12
|
18
|
26
|
28
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
3
|
7
|
8
|
6
|
|
| Total Current Assets |
16
|
29
|
90
|
97
|
70
|
|
| PP&E Net |
6
|
9
|
13
|
23
|
33
|
|
| PP&E Gross |
6
|
9
|
13
|
23
|
33
|
|
| Accumulated Depreciation |
3
|
5
|
9
|
13
|
17
|
|
| Other Long-Term Assets |
1
|
1
|
3
|
5
|
7
|
|
| Total Assets |
23
N/A
|
39
+69%
|
106
+171%
|
124
+17%
|
109
-12%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
3
|
2
|
2
|
|
| Accrued Liabilities |
7
|
7
|
6
|
16
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
3
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
8
|
11
|
8
|
17
|
20
|
|
| Long-Term Debt |
27
|
96
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
42
|
38
|
24
|
|
| Other Liabilities |
1
|
0
|
1
|
3
|
11
|
|
| Total Liabilities |
36
N/A
|
107
+198%
|
51
-53%
|
59
+16%
|
55
-6%
|
|
| Equity | ||||||
| Common Stock |
13
|
68
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
171
|
179
|
173
|
|
| Additional Paid In Capital |
0
|
0
|
227
|
244
|
227
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
13
N/A
|
68
-431%
|
55
N/A
|
65
+18%
|
54
-17%
|
|
| Total Liabilities & Equity |
23
N/A
|
39
+69%
|
106
+171%
|
124
+17%
|
109
-12%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
113
|
113
|
113
|
114
|
128
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
